← Back to Search

Team Intervention Arm for Opioid Use Disorder

N/A
Waitlist Available
Led By Daniel Joseph, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Not homicidal
Refused buprenorphine/naloxone (BUP), if offered
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180 days post intervention
Awards & highlights

Study Summary

This trial is testing a new intervention for people who have overdosed on opioids to see if it can help decrease the number of subsequent overdoses and increase the likelihood of remission from opioid use disorder.

Eligible Conditions
  • Opioid Use Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You do not have thoughts or plans to harm others.
Select...
You declined to take buprenorphine/naloxone (BUP) if it was suggested to you.
Select...
You have been using prescription opioids or heroin, as indicated by a health questionnaire.
Select...
You are not currently taking opioids for pain relief without having a diagnosis of opioid use disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180 days post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 180 days post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Frequency of positive urine tests at 180 days (chart review)
Frequency of positive urine tests at 30 days (chart review)
Frequency of positive urine tests within 180 days (self-report)
+1 more
Secondary outcome measures
Percentage of positive urine tests at 180 days (chart review)
Percentage of positive urine tests at 30 days (chart review)
Percentage of positive urine tests within 180 days (self-report)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Team Intervention ArmExperimental Treatment1 Intervention
Recovery coaches and trained health educators will team together and meet with participants (remotely/electronically and/or by phone or in person, when appropriate) at least twice and for a maximum of 7 times. This includes access to mediation, trained mental healthcare providers, and educational resources.

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,837 Previous Clinical Trials
2,728,332 Total Patients Enrolled
Centers for Disease Control and PreventionFED
873 Previous Clinical Trials
22,467,499 Total Patients Enrolled
Daniel Joseph, MDPrincipal InvestigatorYale University School of Medicine, Yale New Haven Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants still being enrolled for this research?

"Contrary to the initial expectations, clinicaltrials.gov indicates that this trial is not presently open for recruitment; although it was initially posted on July 1st 2020 and last updated on November 9th 2022. However, 535 other trials are currently inviting candidates to participate in their study."

Answered by AI

Does this research endeavor include elderly individuals in its sample population?

"As indicated by the eligibility criteria, patients must be between 18 and 130 years old to participate in this trial. Simultaneously, 89 trials are available for those under 18 while 400 exist for geriatric citizens above 65."

Answered by AI

Am I eligible to be part of this clinical experiment?

"This clinical trial is available to 81 individuals aged 18-130 who are currently struggling with substance abuse. In order to be eligible, participants must not possess any non-opioid related conditions that could explain their decreased level of consciousness, miosis or respiration rate; as well as not being in a critical state at the time of consent (e.g., actively suicidal, psychotic, septic or cardiac arrest). Furthermore, if the prospective participant were discharged from hospital within 7 days prior to joining this study they must meet criteria 3., 4., & 6. Additionally all applicants need to be above the age of majority and able to self"

Answered by AI

What objectives are the researchers striving to accomplish with this experiment?

"This trial, monitored over 6 months post-intervention, is primarily concerned with evaluating the occurrence of positive urine tests at 30 days (as reported by patients). Secondary objectives include assessing the percentage of these evaluations within 180 days via self-report and chart review."

Answered by AI
~17 spots leftby Mar 2025